We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+10.96%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
AUM
$260M
AUM Growth
+$38.4M
Cap. Flow
+$23.3M
Cap. Flow %
8.97%
Top 10 Hldgs %
17.93%
Holding
903
New
107
Increased
159
Reduced
232
Closed
173

Top Sells

Rank Stock Value
1
IRM icon
Iron Mountain
IRM
+$2.41M
2
KLAC icon
KLA
KLAC
+$2.11M
3
CAH icon
Cardinal Health
CAH
+$1.92M
4
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$1.89M
5
STAG icon
STAG Industrial
STAG
+$1.76M

Sector Composition

Rank Sector Weight
1 Technology 26.37%
2 Industrials 14.32%
3 Real Estate 12.48%
4 Financials 10.15%
5 Healthcare 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBI
526
DELISTED
Hanesbrands
HBI
$6.7K ﹤0.01%
1,155
TMDX icon
527
Transmedics
TMDX
$3.01B
$6.66K ﹤0.01%
90
AZN icon
528
AstraZeneca
AZN
$247B
$6.64K ﹤0.01%
49
AI icon
529
C3.ai
AI
$1.62B
$6.63K ﹤0.01%
245
KYMR icon
530
Kymera Therapeutics
KYMR
$9.02B
$6.55K ﹤0.01%
163
APOG icon
531
Apogee Enterprises
APOG
$908M
$6.51K ﹤0.01%
+110
New +$6.08K
IXC icon
532
iShares Global Energy ETF
IXC
$2.74B
$6.44K ﹤0.01%
150
MBLY icon
533
Mobileye
MBLY
$7.48B
$6.43K ﹤0.01%
200
GGN
534
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$830M
$6.36K ﹤0.01%
+1,648
New +$6.2K
EXAS
535
DELISTED
Exact Sciences
EXAS
$6.28K ﹤0.01%
91
CPRX
536
DELISTED
Catalyst Pharmaceutical
CPRX
$6.23K ﹤0.01%
391
BDX icon
537
Becton Dickinson
BDX
$49.2B
$6.19K ﹤0.01%
25
CBIO
538
Crescent Biopharma
CBIO
$627M
$6.17K ﹤0.01%
21
ITCI
539
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6.16K ﹤0.01%
89
FOX icon
540
Fox Class B
FOX
$23.1B
$5.94K ﹤0.01%
208
+1
+0.5% +$28
NLY icon
541
Annaly Capital Management
NLY
$17.4B
$5.91K ﹤0.01%
300
-4,625
-94% -$89.2K
OZK icon
542
Bank OZK
OZK
$5.66B
$5.86K ﹤0.01%
+129
New +$5.78K
TMO icon
543
Thermo Fisher Scientific
TMO
$222B
$5.81K ﹤0.01%
10
TYG
544
Tortoise Energy Infrastructure Corp
TYG
$1.09B
$5.78K ﹤0.01%
187
BTI icon
545
British American Tobacco
BTI
$122B
$5.58K ﹤0.01%
183
ARDX icon
546
Ardelyx
ARDX
$997M
$5.44K ﹤0.01%
745
+100
+16% +$855
PDSB icon
547
PDS Biotechnology
PDSB
$13.9M
$5.43K ﹤0.01%
1,372
EYPT icon
548
EyePoint Inc
EYPT
$1.09B
$5.33K ﹤0.01%
258
PPLI
549
People Inc
PPLI
$3B
$5.26K ﹤0.01%
177
-92
-34% -$3.97K
CDNA icon
550
CareDx
CDNA
$2.47B
$5.25K ﹤0.01%
496

Similar funds

Truvestments Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Truvestments Capital held 903 positions worth $260M, up 17% from $221M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Truvestments Capital deployed $23.3M of net new capital in Q1 2024, opening 107 new positions and adding to 159 existing holdings. Its largest new stake was Pennant Park Investment Corp: 282,183 shares worth $1.94M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Industrials and Real Estate.

On the sell side, the largest reduction was Iron Mountain, an estimated $2.41M trimmed.

  • Truvestments Capital's largest Q1 2024 buy was Pennant Park Investment Corp: 282,183 shares worth $1.94M.
  • Truvestments Capital added most to Archer Daniels Midland in Q1 2024, an estimated $2.07M increase.
  • Truvestments Capital's biggest Q1 2024 reduction was Iron Mountain, cutting an estimated $2.41M.
  • Truvestments Capital fully exited SPIRIT REALTY CAPITAL, INC. in Q1 2024, selling an estimated $1.89M.
  • Truvestments Capital's ten largest holdings make up 18% of its $260M portfolio in Q1 2024.
  • Truvestments Capital opened 107 new positions and closed 173 in Q1 2024.
  • Truvestments Capital's portfolio value rose 17% quarter-over-quarter to $260M.

Based on Truvestments Capital's 13F filing for Q1 2024, filed 14 May 2024.